biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Zack's

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Jan 09, 2023 6:10am

164 Views

Post# 35210457

RE:RE:RE:RE:RE:Zack's

Hummmmm,,,,well if we are in such a dire situation then the rumblings behind the scene might come to fruition!..I hear a couple of larger shareholders talking and recommending a class action. Not that far off the mark when you think about it. I will continue the chat with these others. There maybe some interesting times ahead after all!!. The devil will be in the details. I am sure more discussion is to come.

Any shareholder interested in the above can inbox me and Ill send the info out so we can get numbers down!

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December